Doctor profile · Federal record
Dr. Leslie Markle, MD
Dermatology Physician (CMS: Dermatology) · Tyler, TX
- NPI 1225264443
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 17 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1367 Dominion Plz
Tyler, TX 757031013
(903) 534-6200
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- August 4, 2017
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #P3926
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1225264443. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,610
Distinct HCPCS
10
Medicare allowed
$503,216
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 5,104 | 701 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,817 | 1,294 | $87 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,212 | 879 | $49 | |
17110 |
Destruction of skin growth, 1-14 growths | 544 | 471 | $106 | |
11102 |
Biopsy of related skin growth, first growth | 508 | 431 | $85 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 188 | 155 | $121 | |
11103 |
Biopsy of related skin growth, each additional growth | 175 | 128 | $48 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 144 | 144 | $107 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 127 | 102 | $162 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 110 | 33 | $1 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 305. This provider delivers 35× the peer median.Open Payments
Industry payments received
All-time total
$2,235
Transactions
105
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 39 | $652.01 | |
| Janssen Biotech, Inc. | 24 | $635.24 | |
| Regeneron Healthcare Solutions, Inc. | 11 | $302.13 | |
| GENZYME CORPORATION | 10 | $235.71 | |
| Lilly USA, LLC | 6 | $106.16 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $61.22 | |
| Dermavant Sciences, Inc. | 2 | $36.57 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35.63 | |
| Arcutis Biotherapeutics, Inc. | 2 | $30.95 | |
| LEO Pharma Inc. | 1 | $26.15 | |
| UCB, Inc. | 1 | $23.90 | |
| Amgen Inc. | 1 | $21.88 | |
| Incyte Corporation | 1 | $18.35 | |
| Galderma Laboratories, L.P. | 1 | $16.72 | |
| Novartis Pharmaceuticals Corporation | 1 | $16.52 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,423
Patients
770
Total drug cost
$266,086
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 227 | 133 | $5,504 |
| Betamethasone Dipropionate | Generic | 180 | 119 | $9,648 |
| Triamcinolone Acetonide | Generic | 180 | 130 | $1,948 |
| Doxycycline Hyclate | Generic | 153 | 86 | $3,274 |
| Dutasteride | Generic | 103 | 26 | $2,028 |
| Clobetasol Propionate | Generic | 93 | 56 | $5,528 |
| Mupirocin | Generic | 86 | 68 | $746 |
| Hydrocortisone | Generic | 80 | 59 | $463 |
| Hydroxychloroquine Sulfate | Generic | 54 | 13 | $2,768 |
| Dupixent Pen (Dupilumab) | Brand | 52 | 0 | $227,813 |
Frequently asked questions
What is Dr. Leslie Markle's medical specialty?
Dr. Leslie Markle practices Dermatology Physician in Tyler, TX.
Where does Dr. Leslie Markle practice?
Dr. Leslie Markle practices at 1367 Dominion Plz, Tyler, TX 757031013. Office phone: 9035346200.
What is Dr. Leslie Markle's NPI?
Dr. Leslie Markle's National Provider Identifier (NPI) is 1225264443, issued by NPPES.
Does Dr. Leslie Markle accept Medicare assignment?
Yes. Dr. Leslie Markle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Leslie Markle commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.